More NewsGenesis Biopharma Names Michael Handelman as CFO and Treasurer

Genesis Biopharma Names Michael Handelman as CFO and Treasurer

Genesis Biopharma, a biotechnology company developing targeted cancer therapies, has named Michael Handelman as chief financial officer (CFO), treasurer and secretary, succeeding Richard McKilligan.

Handelman currently serves as the CFO of Oxis International. Before joining Oxis, he served as CFO and chief operating officer (COO) of TechnoConcepts, a developing technology and manufacturing company. Prior to that, he was CFO of Interglobal Waste Management, a start-up manufacturing company. Handelman has also been CFO of the Los Angeles Kings, a National Hockey League franchise. He is a certified public accountant (CPA) and holds a degree in accounting from the City University of New York.

Related Articles

Infosys Finacle to power Santander UK’s international cash management system

More News Infosys Finacle to power Santander UK’s international cash management system

3w The Global Treasurer
Preparing for GDPR? Here’s four things to consider

More News Preparing for GDPR? Here’s four things to consider

4m Elliott Wiseman
Cash flow in focus for investors

Cash Management Cash flow in focus for investors

5m Conor Deegan
Treasury TV: Karen Pugsley, Domino's Pizza Group

More News Treasury TV: Karen Pugsley, Domino's Pizza Group

5m Victoria Beckett
Treasury TV: Yeng Butler compares US and European MMF reforms

Compliance Treasury TV: Yeng Butler compares US and European MMF reforms

5m Victoria Beckett
Treasury TV: Tim de Knegt, The Port of Rotterdam

10 Minutes With The Treasury Treasury TV: Tim de Knegt, The Port of Rotterdam

5m Victoria Beckett
Banks are selling clients short with short dated cash deposit U-turns

Banking Banks are selling clients short with short dated cash deposit U-turns

5m Victoria Beckett
What does sterling’s Brexit boost mean for UK manufacturers?

More News What does sterling’s Brexit boost mean for UK manufacturers?

6m Tasja Botha